Columbus McKinnon to Acquire Garvey Corporation

November 4, 2021

1

Safe Harbor Statement

These slides, and the accompanying oral discussion (together, this "presentation"), contain "forward-looking statements" within the meaning

of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements concerning future sales and earnings, which involve known and unknown risks, uncertainties and other factors that could cause the actual results of the Company to differ materially from the results expressed or implied by such statements, including the ability of the Company to complete the acquisition of Garvey, the integration of Garvey into the Company to achieve cost and revenue synergies, the ability of the Company and Garvey to achieve revenue expectations, the ability of the Company to execute its financing plans in connection with the Garvey acquisition, global economic and business conditions including the impact of COVID-19, conditions affecting the industries served by the Company and its subsidiaries, conditions affecting the Company's customers and suppliers, competitor responses to the Company's products and services, the overall market acceptance of such products and services, the ability to expand into new markets and geographic regions, and other factors disclosed in the Company's periodic reports filed with the Securities and Exchange Commission. The Company assumes no obligation to update the forward-looking information contained in this release.

2

Executing our Blueprint for Growth 2.0

Transforming Columbus McKinnon into a high value, intelligent motion enterprise

3

Acquiring Garvey Corporation

Leader in accumulation technology complements Dorner's conveying solutions

Provides unique, patented technologiesin the design,

application, manufacturing and integration of accumulation systems

Industries highest quality products, deep technical expertise and experienced management team

Strong brand namerecognition in pharmaceutical and food & beverage industries

Strong top-linegrowth and profitability

  • TTM Revenue ~$30M at September 30, 2021
  • 100% of revenue in North America
  • ~80%+ sales in F&B and Pharma
  • TTM Adjusted EBITDA ~$9M at September 30, 2021
  • Expect $0.05 GAAP EPS accretion in fiscal 2023

Headquartered in Hammonton, New Jersey

Products

Accumulators

46% of Revenue

Specialty Conveyors

30% of Revenue

Vial Loaders,

Lubrication Systems,

Gripper Elevators

24% of Revenue

Leading automation solutions company concentrated in F&B and pharma

4

Excellent Strategic Fit for CMCO's Conveying Solutions

  • Accumulation technologies highly complementary to Dorner's conveying technologies
  • Various Technologies within $500M Accumulation Market

✓ Products Garvey can accumulate:

Bi-Flow

Spiral

Mass Flow

Recirculating

Serpentine

Significant cross-sell opportunities to further expand into new markets

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Columbus McKinnon Corporation published this content on 04 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 November 2021 12:44:08 UTC.